Jakubowitz Law
NEW YORK, NY / ACCESSWIRE / July 21, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Washington Prime Group, Inc. (NYSE:WPG)
CONTACT JAKUBOWITZ ABOUT WPG:
https://claimyourloss.com/securities/washington-prime-group-inc-loss-submission-form/?id=17848&from=1
Class Period : November 5, 2020 - March 4, 2021
Lead Plaintiff Deadline : July 23, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) WPG's financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company's ability to meet its capital structure obligations as they became due; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Frequency Therapeutics, Inc. (NASDAQ:FREQ)
CONTACT JAKUBOWITZ ABOUT FREQ:
https://claimyourloss.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17848&from=1
Class Period : November 16, 2020 - March 22, 2021
Lead Plaintiff Deadline : August 2, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.
Renovacare, Inc. (OTC PINK:RCAR)
CONTACT JAKUBOWITZ ABOUT RCAR:
https://claimyourloss.com/securities/renovacare-inc-loss-submission-form/?id=17848&from=1
Class Period : August 14, 2017 - May 28, 2021
Lead Plaintiff Deadline : September 14, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) at the direction of Harmel Rayat, RenovaCare engaged in a promotional campaign to issue misleading statements to artificially inflate the Company's stock price; (2) when the OTC Markets inquired, RenovaCare and Mr. Rayat issued a materially false and misleading press release claiming that no director, officer, or controlling shareholder had any involvement in the purported third party's promotional materials; (3) as a result of the foregoing, the Company's disclosure controls and procedures were defective; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/656485/LAWSUITS-FILED-AGAINST-WPG-FREQ-and-RCAR--Jakubowitz-Law-Pursues-Shareholders-Claims
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Seyond18.4.2024 12:03:28 CEST | Press release
Seyond's High-Performance LiDAR Technology Powers the Future of Autonomous Racing
Loar Holdings, LLC17.4.2024 12:32:14 CEST | Press release
Loar Announces Launch of Initial Public Offering
Workwell Technologies Inc.17.4.2024 09:02:09 CEST | Press release
Chronologic, Ltd Becomes Part of Workwell Technologies Following Acquisition
Cactus Life Sciences16.4.2024 18:22:07 CEST | Press release
Cactus Life Sciences Announces Appointment of Oliver Dennis as Chairman to Shape the Agency of the Future
Tau11.4.2024 22:21:03 CEST | Press release
Tau Unveils Groundbreaking Research in Logical Languages to Transform Software Development
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom